Private Equity Firm Profile
In the last 3 years, ArchiMed has acquired 13 companies. It has also invested in 4 others.
ArchiMed’s most common sectors for investment arelife science (37%) and medical products (25%) . The Firm’s most common investment types include buyout (lbo, mbo, mbi) (56%) and growth capital (20%). In total, ArchiMed has invested in 8 US states and 11 different countries. Its largest (disclosed) acquisition occurred in 2022 when it acquired Natus Medical for $1.1B.
In the last 3 years, ArchiMed has exited 7 companies. The Firm’s most common exit type is trade sale (89%). ArchiMed’s largest (disclosed) exit occurred in 2023 when it sold Polyplus-transfection SA for $2.7B.
Join Mergr to view ArchiMed’s full profile and discover more mega-sized private equity firm investors just like it.
M&A Summary
-
M&A Total Activity45
- M&A Buy Activity36
- M&A Sell Activity9
- Total Sectors Invested 9
- Total Countries Invested 11
- M&A Buy/Sell Connections 10
- M&A Advisors 4